According to Axogen's latest financial reports the company's current earnings (TTM) are -$21.72 M. In 2022 the company made an earning of -$28.95 M a decrease over its 2021 earnings that were of -$26.99 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$21.72 M | -24.98% |
2022 | -$28.95 M | 7.27% |
2021 | -$26.99 M | 13.45% |
2020 | -$23.79 M | -18.36% |
2019 | -$29.14 M | 30.08% |
2018 | -$22.4 M | 114.43% |
2017 | -$10.45 M | -27.52% |
2016 | -$14.42 M | 7.9% |
2015 | -$13.36 M | -24.58% |
2014 | -$17.72 M | 21.66% |
2013 | -$14.56 M | 43.33% |
2012 | -$10.16 M | 11.32% |
2011 | -$9.13 M | 322.38% |
2010 | -$2.17 M | -113.54% |
2009 | $15.95 M | -1609.9% |
2008 | -$1.06 M | 32.11% |
2007 | -$0.8 M | 80.55% |
2006 | -$0.45 M | 35.69% |
2005 | -$0.33 M | -196.65% |
2004 | $0.33 M | -126.42% |
2003 | -$1.28 M | -51.35% |
2002 | -$2.63 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Medtronic MDT | $6.23 B | -28,811.55% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | $6.29 B | -29,101.66% | ๐บ๐ธ USA |
Boston Scientific BSX | $1.98 B | -9,240.73% | ๐บ๐ธ USA |